Photodynamic therapy (PDT) is a treatment based on the accumulation of a photosensitizer in the target cells and their selective destruction by irradiation with visible light. In the past 10 years, several patients wi...Photodynamic therapy (PDT) is a treatment based on the accumulation of a photosensitizer in the target cells and their selective destruction by irradiation with visible light. In the past 10 years, several patients with cutaneous T cell lymphoma have been successfully treated. The use of PDT in cutaneous B cell lymphoma has not been reported to date. We report the successful PDT treatment of 3 patients with early primary cutaneousBcell lymphoma.展开更多
1型糖尿病(diabetes mellitus type 1,T1DM)是遗传易感个体在环境因素的触发下,由T淋巴细胞介导的以胰岛β细胞选择性破坏为特征的器官特异性自身免疫性疾病[1]。对于大多数1型糖尿病患者,通过胰岛素治疗、血糖监测和饮食控制是可以合...1型糖尿病(diabetes mellitus type 1,T1DM)是遗传易感个体在环境因素的触发下,由T淋巴细胞介导的以胰岛β细胞选择性破坏为特征的器官特异性自身免疫性疾病[1]。对于大多数1型糖尿病患者,通过胰岛素治疗、血糖监测和饮食控制是可以合理控制血糖水平的。但胰岛素治疗有发生致命性低糖血症的可能,因严重低糖血症死亡的1型糖尿病患者甚至可以达到10%[2]。展开更多
文摘Photodynamic therapy (PDT) is a treatment based on the accumulation of a photosensitizer in the target cells and their selective destruction by irradiation with visible light. In the past 10 years, several patients with cutaneous T cell lymphoma have been successfully treated. The use of PDT in cutaneous B cell lymphoma has not been reported to date. We report the successful PDT treatment of 3 patients with early primary cutaneousBcell lymphoma.
文摘1型糖尿病(diabetes mellitus type 1,T1DM)是遗传易感个体在环境因素的触发下,由T淋巴细胞介导的以胰岛β细胞选择性破坏为特征的器官特异性自身免疫性疾病[1]。对于大多数1型糖尿病患者,通过胰岛素治疗、血糖监测和饮食控制是可以合理控制血糖水平的。但胰岛素治疗有发生致命性低糖血症的可能,因严重低糖血症死亡的1型糖尿病患者甚至可以达到10%[2]。